➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKesson
Colorcon
Baxter
Medtronic
McKinsey

Last Updated: September 26, 2020

DrugPatentWatch Database Preview

Patent: 8,709,484

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,709,484
Title:Phospholipid-based powders for drug delivery
Abstract: Phospholipid based powders for drug delivery applications are disclosed. The powders may include a polyvalent cation in an amount effective to increase the gel-to-liquid crystal transition temperature of the particle compared to particles without the polyvalent cation. The powders are hollow and porous and are preferably administered via inhalation.
Inventor(s): Weers; Jeffry G. (Half Moon Bay, CA), Tarara; Thomas E. (Burlingame, CA), Dellamary; Luis A. (San Marcos, CA), Riess; Jean G. (Falicon, FR), Schutt; Ernest G. (San Diego, CA)
Assignee: Novartis AG (Basel, CH)
Application Number:12/258,163
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,709,484
Patent Claims:see list of patent claims

Details for Patent 8,709,484

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genzyme CEREZYME imiglucerase INJECTABLE;INJECTION 020367 001 1995-04-07   Start Trial Novartis AG (Basel, CH) 2020-05-10 RX search
Genzyme CEREZYME imiglucerase INJECTABLE;INJECTION 020367 002 1995-04-07   Start Trial Novartis AG (Basel, CH) 2020-05-10 RX search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 001 2015-01-23   Start Trial Novartis AG (Basel, CH) 2020-05-10 RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 002 2015-01-23   Start Trial Novartis AG (Basel, CH) 2020-05-10 RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 003 2015-01-23   Start Trial Novartis AG (Basel, CH) 2020-05-10 RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 004 2015-01-23   Start Trial Novartis AG (Basel, CH) 2020-05-10 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Boehringer Ingelheim
Medtronic
Harvard Business School
Mallinckrodt
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.